Citations (92)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Nidhi Chauhan, Sukirti Tiwari, Tessy Iype & Utkarsh Jain. (2017) An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators. Expert Review of Vaccines 16:5, pages 491-502.
Read now
Read now
Marco Pravetoni. (2016) Biologics to treat substance use disorders: Current status and new directions. Human Vaccines & Immunotherapeutics 12:12, pages 3005-3019.
Read now
Read now
A. L. Silva, P. C. Soema, B. Slütter, F. Ossendorp & W. Jiskoot. (2016) PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity. Human Vaccines & Immunotherapeutics 12:4, pages 1056-1069.
Read now
Read now
Mojgan Allahyari & Elham Mohit. (2016) Peptide/protein vaccine delivery system based on PLGA particles . Human Vaccines & Immunotherapeutics 12:3, pages 806-828.
Read now
Read now
Małgorzata Anna Marć, Enrique Domínguez-Álvarez & Carlos Gamazo. (2015) Nucleic acid vaccination strategies against infectious diseases. Expert Opinion on Drug Delivery 12:12, pages 1851-1865.
Read now
Read now
Karen AO Martins, Sina Bavari & Andres M Salazar. (2015) Vaccine adjuvant uses of poly-IC and derivatives. Expert Review of Vaccines 14:3, pages 447-459.
Read now
Read now
H. Lebrec, M. B. Hock, J. S. Sundsmo, D. T. Mytych, H. Chow, L. L. Carlock, M. K. Joubert, J. Reindel, L. Zhou & J. L. Bussiere. (2014) T-cell-dependent antibody responses in the rat: Forms and sources of keyhole limpet hemocyanin matter. Journal of Immunotoxicology 11:3, pages 213-221.
Read now
Read now
Nian-Zhang Zhang, Jia Chen, Meng Wang, Eskild Petersen & Xing-Quan Zhu. (2013) Vaccines against Toxoplasma gondii: new developments and perspectives. Expert Review of Vaccines 12:11, pages 1287-1299.
Read now
Read now
Ana Isabel Camacho, Juan Manuel Irache & Carlos Gamazo. (2013) Recent progress towards development of a Shigella vaccine. Expert Review of Vaccines 12:1, pages 43-55.
Read now
Read now
Articles from other publishers (83)
Eric A. Toth, Alexander K. Andrianov & Thomas R. Fuerst. (2023) Prospects for developing an Hepatitis C virus E1E2‐based nanoparticle vaccine. Reviews in Medical Virology.
Crossref
Crossref
Dattatreya Mukherjee, Rajib Dhar, Arikketh Devi, Sukhamoy Gorai, Raman Muthusamy, Pitchaipillai S. Ganesh, Saurabh K. Jha & Aymar Akilimali. (2023) Exosome-based malaria vaccine, a miracle of nanomedicine. International Journal of Surgery: Global Health 6:3.
Crossref
Crossref
Michael Lueckheide, Alexander Marin, Harichandra D. Tagad, Nicholas D. Posey, Vivek M. Prabhu & Alexander K. Andrianov. (2023) Monitoring Protein Complexation with Polyphosphazene Polyelectrolyte Using Automated Dynamic Light Scattering Titration and Asymmetric Flow Field Flow Fractionation and Protein Recognition Immunoassay. ACS Polymers Au.
Crossref
Crossref
Jilan A. Nazeam & Abdel Nasser B. Singab. (2022) Immunostimulant plant proteins: Potential candidates as vaccine adjuvants. Phytotherapy Research 36:12, pages 4345-4360.
Crossref
Crossref
Namrata Baruah, Prolay Halder, Hemanta Koley & Dhirendra S. Katti. (2022) Stable Recombinant Invasion Plasmid Antigen C (IpaC)-Based Single Dose Nanovaccine for Shigellosis. Molecular Pharmaceutics 19:11, pages 3884-3893.
Crossref
Crossref
Adam M. Weiss, Samir Hossainy, Stuart J. Rowan, Jeffrey A. Hubbell & Aaron P. Esser-Kahn. (2022) Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems. Macromolecules 55:16, pages 6913-6937.
Crossref
Crossref
Mojgan Allahyari. (2022) PLGA Nanoparticles as an Efficient Platform in Protein Vaccines Against Toxoplasma gondii. Acta Parasitologica 67:2, pages 582-591.
Crossref
Crossref
Bali Pulendran, Prabhu S. Arunachalam & Derek T. O’Hagan. (2021) Emerging concepts in the science of vaccine adjuvants. Nature Reviews Drug Discovery 20:6, pages 454-475.
Crossref
Crossref
Alexander K. Andrianov & Thomas R. Fuerst. (2021) Immunopotentiating and Delivery Systems for HCV Vaccines. Viruses 13:6, pages 981.
Crossref
Crossref
Giulia Anderluzzi, Signe Tandrup Schmidt, Robert Cunliffe, Stuart Woods, Craig W. Roberts, Daniele Veggi, Ilaria Ferlenghi, Derek T. O'Hagan, Barbara C. Baudner & Yvonne Perrie. (2021) Rational design of adjuvants for subunit vaccines: The format of cationic adjuvants affects the induction of antigen-specific antibody responses. Journal of Controlled Release 330, pages 933-944.
Crossref
Crossref
Nagham Gamal Masoud, Nagwa Mostafa El-Sayed & Manar Ezz Elarab Ramadan. 2021. Role of Exosomes in Biological Communication Systems. Role of Exosomes in Biological Communication Systems
261
276
.
Sandra Jesus, Natalia Bernardi, Jessica da Silva, Mariana Colaço, João Panão Costa, Pedro Fonte & Olga Borges. (2020) Unravelling the Immunotoxicity of Polycaprolactone Nanoparticles—Effects of Polymer Molecular Weight, Hydrolysis, and Blends. Chemical Research in Toxicology 33:11, pages 2819-2833.
Crossref
Crossref
Sören Reinke, Aneesh Thakur, Cillian Gartlan, Jelena S. Bezbradica & Anita Milicic. (2020) Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants. Vaccines 8:3, pages 554.
Crossref
Crossref
Giuseppe Lofano, Corey P. Mallett, Sylvie Bertholet & Derek T. O’Hagan. (2020) Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines. npj Vaccines 5:1.
Crossref
Crossref
Derek T. O’Hagan, Rushit N. Lodaya & Giuseppe Lofano. (2020) The continued advance of vaccine adjuvants – ‘we can work it out’. Seminars in Immunology 50, pages 101426.
Crossref
Crossref
Sudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, Mathew Pham, Traci Legere, Zarpheen Jinnah SherYevgeny Kovalenkov, Sanjeev Gumber, Jessica Y. Huang, Raphael Gottardo, William FulpAlicia Sato, Sheetal Sawant, Sherry Stanfield-Oakley, Nicole Yates, Celia LaBranche, S. Munir Alam, Georgia TomarasGuido FerrariDavid Montefiori, Jens Wrammert, Francois Villinger, Mark Tomai, John VasilakosChristopher B. Fox, Steven G. ReedBarton F. HaynesShane Crotty, Rafi Ahmed & Bali Pulendran. (2020) 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates. Science Immunology 5:48.
Crossref
Crossref
Mojgan Allahyari, Reyhaneh Mohabati, Alireza Vatanara & Majid Golkar. (2020) In-vitro and in-vivo comparison of rSAG1-loaded PLGA prepared by encapsulation and adsorption methods as an efficient vaccine against Toxoplasma gondii”. Journal of Drug Delivery Science and Technology 55, pages 101327.
Crossref
Crossref
Shang-Pin Liu, Shu-Chun Chuang & Chung-Da Yang. (2020) Protective Immunity against Vibrio harveyi in Grouper Induced by Single Vaccination with Poly (Lactide-co-glycolide) Microparticles Releasing Pleurocidin Peptide and Recombinant Glyceraldehyde-3-phosphate Dehydrogenase. Vaccines 8:1, pages 33.
Crossref
Crossref
Atin Khalaj‐Hedayati, Caroline Lin Lin Chua, Peter Smooker & Khai Wooi Lee. (2019) Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement. Influenza and Other Respiratory Viruses 14:1, pages 92-101.
Crossref
Crossref
Daniel Crístian Ferreira Soares, Larissa Moro Soares, Alfredo Miranda de Goes, Eliza Mathias Melo, André Luis Branco de Barros, Thaís Carolina Alves Santos Bicalho, Nadia Miriceia Leao & Marli Luiza Tebaldi. (2020) Mesoporous SBA-16 silica nanoparticles as a potential vaccine adjuvant against Paracoccidioides brasiliensis. Microporous and Mesoporous Materials 291, pages 109676.
Crossref
Crossref
Joon Haeng Rhee. 2020. Mucosal Vaccines. Mucosal Vaccines
325
356
.
Jessica C. Joyce, Hila E. Sella, Heather Jost, Matthew J. Mistilis, E. Stein Esser, Pallab Pradhan, Randall Toy, Marcus L. Collins, Paul A. Rota, Krishnendu Roy, Ioanna Skountzou, Richard W. Compans, M. Steven Oberste, William C. Weldon, James J. Norman & Mark R. Prausnitz. (2019) Extended delivery of vaccines to the skin improves immune responses. Journal of Controlled Release 304, pages 135-145.
Crossref
Crossref
Pingsheng Huang, Xiaoli Wang, Xiaoyu Liang, Jing Yang, Chuangnian Zhang, Deling Kong & Weiwei Wang. (2019) Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy. Acta Biomaterialia 85, pages 1-26.
Crossref
Crossref
Masoud Foroutan, Fatemeh Ghaffarifar, Zohreh Sharifi, Abdolhosein Dalimi & Ogholniaz Jorjani. (2019)
Rhoptry antigens as
Toxoplasma gondii
vaccine target
. Clinical and Experimental Vaccine Research 8:1, pages 4.
Crossref
Crossref
EmrahSefik Abamor, Adil Allahverdiyev, OzlemAyse Tosyali, Melahat Bagirova, Tayfun Acar, Zeynep Mustafaeva & Serap Derman. (2019) Evaluation of in vitro and in vivo immunostimulatory activities of poly (lactic-co-glycolic acid) nanoparticles loaded with soluble and autoclaved Leishmania infantum antigens: A novel vaccine candidate against visceral leishmaniasis. Asian Pacific Journal of Tropical Medicine 12:8, pages 353.
Crossref
Crossref
Qi Liu, Xiaoming Chen, Jilei Jia, Ting Lu, Tingyuan Yang & Lianyan Wang. (2018) Potential Hepatitis B Vaccine Formulation Prepared by Uniform-Sized Lipid Hybrid PLA Microparticles with Adsorbed Hepatitis B Surface Antigen. Molecular Pharmaceutics 15:11, pages 5227-5235.
Crossref
Crossref
Tamiru Negash Alkie, Alexander Yitbarek, Khaled Taha-Abdelaziz, Jake Astill & Shayan Sharif. (2018) Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens. PLOS ONE 13:11, pages e0206324.
Crossref
Crossref
M. A. Myagkova & V. S. Morozova. (2018) Vaccines for substance abuse treatment: new approaches in the immunotherapy of addictions. Russian Chemical Bulletin 67:10, pages 1781-1793.
Crossref
Crossref
Qian Wang, Meagan A. Barry, Christopher A. Seid, Elissa M. Hudspeth, C. Patrick McAtee & Michael J. Heffernan. (2018)
3M-052 as an adjuvant for a PLGA microparticle-based
Leishmania donovani
recombinant protein vaccine
. Journal of Biomedical Materials Research Part B: Applied Biomaterials 106:4, pages 1587-1594.
Crossref
Crossref
Masoud Foroutan & Fatemeh Ghaffarifar. (2018)
Calcium-dependent protein kinases are potential targets for
Toxoplasma gondii
vaccine
. Clinical and Experimental Vaccine Research 7:1, pages 24.
Crossref
Crossref
Natalia Guimaraes Sampaio, Lesley Cheng & Emily M. Eriksson. (2017) The role of extracellular vesicles in malaria biology and pathogenesis. Malaria Journal 16:1.
Crossref
Crossref
Britta Furtmann, Justin Tang, Sven Kramer, Thomas Eickner, Frank Luderer, Gert Fricker, Alessandro Gomez, Bianca Heemskerk & Peter S. Jähn. (2017) Electrospray Synthesis of Poly(lactide-co-glycolide) Nanoparticles Encapsulating Peptides to Enhance Proliferation of Antigen-Specific CD8+ T Cells. Journal of Pharmaceutical Sciences 106:11, pages 3316-3327.
Crossref
Crossref
Chung‐Da Yang. 2017. Toxoplasmosis. Toxoplasmosis.
Edecio Cunha-Neto, Daniela S. Rosa, Paul E. Harris, Tim Olson, Alex Morrow, Serban Ciotlos, Charles V. Herst & Reid Martin Rubsamen. (2017) An Approach for a Synthetic CTL Vaccine Design against Zika Flavivirus Using Class I and Class II Epitopes Identified by Computer Modeling. Frontiers in Immunology 8.
Crossref
Crossref
Tamiru N. Alkie, Khaled Taha-Abdelaziz, Neda Barjesteh, Jegarubee Bavananthasivam, Douglas C. Hodgins & Shayan Sharif. (2017) Characterization of Innate Responses Induced by PLGA Encapsulated- and Soluble TLR Ligands In Vitro and In Vivo in Chickens. PLOS ONE 12:1, pages e0169154.
Crossref
Crossref
Jilei Jia, Weifeng Zhang, Qi Liu, Tingyuan Yang, Lianyan Wang & Guanghui Ma. (2016) Adjuvanticity Regulation by Biodegradable Polymeric Nano/microparticle Size. Molecular Pharmaceutics 14:1, pages 14-22.
Crossref
Crossref
Shu-Chun Chuang, Yao-Chi Chung & Chung-Da Yang. (2017) Protective immunity against toxoplasmosis in mice induced by single-dose immunization with rSAG1/2 protein released from poly(lactide-co-glycolide) microparticles. Parasite 24, pages 5.
Crossref
Crossref
N. Muñoz-Wolf, S. McCluskey & E.C. Lavelle. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
23
42
.
Habibun Nabi, Imran Rashid, Nisar Ahmad, Aneela Durrani, Haroon Akbar, Saher Islam, Amna Arshad Bajwa, Wasim Shehzad, Kamran Ashraf & Nyla Imran. (2016) Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from Toxoplasma gondii. Parasitology Research 116:1, pages 359-370.
Crossref
Crossref
Ruchi R. Shah, Kimberly J. Hassett & Luis A. Brito. 2017. Vaccine Adjuvants. Vaccine Adjuvants
1
13
.
Mojgan Allahyari, Reyhaneh Mohabati, Samira Amiri, Ahmad Reza Esmaeili Rastaghi, Jalal Babaie, Mehdi Mahdavi, Alireza Vatanara & Majid Golkar. (2016) Synergistic effect of rSAG1 and rGRA2 antigens formulated in PLGA microspheres in eliciting immune protection against Toxoplasama gondii. Experimental Parasitology 170, pages 236-246.
Crossref
Crossref
Joseph R. Francica, Geoffrey M. Lynn, Richard Laga, M. Gordon Joyce, Tracy J. Ruckwardt, Kaitlyn M. Morabito, Man Chen, Rajoshi Chaudhuri, Baoshan Zhang, Mallika Sastry, Aliaksandr Druz, Kiyoon Ko, Misook Choe, Michal Pechar, Ivelin S. Georgiev, Lisa A. Kueltzo, Leonard W. SeymourJohn R. Mascola, Peter D. Kwong, Barney S. Graham & Robert A. Seder. (2016) Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 Adjuvant. Bioconjugate Chemistry 27:10, pages 2372-2385.
Crossref
Crossref
Alice Gutjahr, Capucine Phelip, Anne-Line Coolen, Claire Monge, Anne-Sophie Boisgard, Stéphane Paul & Bernard Verrier. (2016) Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting. Vaccines 4:4, pages 34.
Crossref
Crossref
Shirene M. Singh, Tamiru N. Alkie, Éva Nagy, Raveendra R. Kulkarni, Douglas C. Hodgins & Shayan Sharif. (2016) Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens. Vaccine 34:40, pages 4807-4813.
Crossref
Crossref
Cristina Bruno, Valentina Agnolon, Francesco Berti, Simone Bufali, Derek T. O’Hagan & Barbara C. Baudner. (2016) The preparation and characterization of PLG nanoparticles with an entrapped synthetic TLR7 agonist and their preclinical evaluation as adjuvant for an adsorbed DTaP vaccine. European Journal of Pharmaceutics and Biopharmaceutics 105, pages 1-8.
Crossref
Crossref
Rajeev Sharma, Nishi Mody, Surbhi Dubey, Udita Agrawal & Suresh Vyas. 2016. Handbook of Polyester Drug Delivery Systems. Handbook of Polyester Drug Delivery Systems
479
519
.
Shirene M. SinghTamiru N. AlkieKhaled Taha AbdelazizDouglas C. HodginsAnastasia NovyÉva NagyShayan Sharif. (2016) Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN. Viral Immunology 29:5, pages 269-275.
Crossref
Crossref
Jun Zha, Xiao-wei Chi, Xiao-lin Yu, Xiang-meng Liu, Dong-qun Liu, Jie Zhu, Hui Ji & Rui-tian Liu. (2016) Interleukin-1β-Targeted Vaccine Improves Glucose Control and β-Cell Function in a Diabetic KK-Ay Mouse Model. PLOS ONE 11:5, pages e0154298.
Crossref
Crossref
Wei Wang, Kun Fang, Miao-Chen Li, Di Chang, Khawar Ali Shahzad, Tao Xu, Lei Zhang, Ning Gu & Chuan-Lai Shen. (2016)
A biodegradable killer microparticle to selectively deplete antigen-specific T cells
in vitro
and
in vivo
. Oncotarget 7:11, pages 12176-12190.
Crossref
Crossref
Tyson J. Moyer, Andrew C. Zmolek & Darrell J. Irvine. (2016) Beyond antigens and adjuvants: formulating future vaccines. Journal of Clinical Investigation 126:3, pages 799-808.
Crossref
Crossref
Matthew D. Gallovic, Douglas G. Montjoy, Michael A. Collier, Clement Do, Barbara E. Wyslouzil, Eric M. Bachelder & Kristy M. Ainslie. (2016) Chemically modified inulin microparticles serving dual function as a protein antigen delivery vehicle and immunostimulatory adjuvant. Biomaterials Science 4:3, pages 483-493.
Crossref
Crossref
Karen A.O. Martins, Christopher L. Cooper, Sabrina M. Stronsky, Sarah L.W. Norris, Steven A. Kwilas, Jesse T. Steffens, Jacqueline G. Benko, Sean A. van Tongeren & Sina Bavari. (2016) Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity. EBioMedicine 3, pages 67-78.
Crossref
Crossref
Wenjuan Xu, Jintian He, Guanghao Wu, Fangfang Xiong, Huijuan Du & Gaizhen Wang. (2015) Stabilization and immune response of HBsAg encapsulated within poly(lactic-co-glycolic acid) microspheres using HSA as a stabilizer. International Journal of Pharmaceutics 496:2, pages 332-341.
Crossref
Crossref
Ying Xu, Nian-Zhang Zhang, Meng Wang, Hu Dong, Sheng-Yong Feng, Hui-Chen Guo & Xing-Quan Zhu. (2015) A long-lasting protective immunity against chronic toxoplasmosis in mice induced by recombinant rhoptry proteins encapsulated in poly (lactide-co-glycolide) microparticles. Parasitology Research 114:11, pages 4195-4203.
Crossref
Crossref
Jamal S. Lewis, Natalia V. Dolgova, Ying Zhang, Chang Qing Xia, Clive H. Wasserfall, Mark A. Atkinson, Michael J. Clare-Salzler & Benjamin G. Keselowsky. (2015) A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice. Clinical Immunology 160:1, pages 90-102.
Crossref
Crossref
Jin Huk Choi, Stephen C. Schafer, Alexander N. Freiberg & Maria A. Croyle. (2015) Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola Vaccine. Molecular Pharmaceutics 12:8, pages 2697-2711.
Crossref
Crossref
Fabrice Rose, Jeanette Erbo Wern, Pall Thor Ingvarsson, Marco van de Weert, Peter Andersen, Frank Follmann & Camilla Foged. (2015) Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach. Journal of Controlled Release 210, pages 48-57.
Crossref
Crossref
Derek T. O’Hagan & Christopher B. Fox. (2015) New generation adjuvants – From empiricism to rational design. Vaccine 33, pages B14-B20.
Crossref
Crossref
Adam A Walters, Christos Krastev, Adrian V S Hill & Anita Milicic. (2015) Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy. Journal of Pharmacy and Pharmacology 67:3, pages 400-408.
Crossref
Crossref
Li-Ting Cheng, Yao-Chi Chung, Chung-Da Yang, Kuo-Pin Chuang, Guan-Ming Ke & Chun-Yen Chu. 2015. Biological Toxins and Bioterrorism. Biological Toxins and Bioterrorism
449
467
.
Ruchi R Shah, Derek T O'Hagan, Mansoor M Amiji & Luis A Brito. (2014) The impact of size on particulate vaccine adjuvants. Nanomedicine 9:17, pages 2671-2681.
Crossref
Crossref
Vincent Pavot, Morgane Berthet, Julien Rességuier, Sophie Legaz, Nadège Handké, Sarah C Gilbert, Stéphane Paul & Bernard Verrier. (2014)
Poly(lactic acid) and poly(lactic-
co
-glycolic acid) particles as versatile carrier platforms for vaccine delivery
. Nanomedicine 9:17, pages 2703-2718.
Crossref
Crossref
SHU-CHUN CHUANG & CHUNG-DA YANG. (2014)
Sustained release of recombinant surface antigen 2 (rSAG2) from poly(lactide-co-glycolide) microparticles extends protective cell-mediated immunity against
Toxoplasma gondii
in mice
. Parasitology 141:12, pages 1657-1666.
Crossref
Crossref
Jane Bryant, Kelan A. Hlavaty, Xiaomin Zhang, Woon-Teck Yap, Lei Zhang, Lonnie D. Shea & Xunrong Luo. (2014) Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation. Biomaterials 35:31, pages 8887-8894.
Crossref
Crossref
Preety Sahdev, Lukasz J. Ochyl & James J. Moon. (2014) Biomaterials for Nanoparticle Vaccine Delivery Systems. Pharmaceutical Research 31:10, pages 2563-2582.
Crossref
Crossref
Luis A. Brito & Derek T. O'Hagan. (2014) Designing and building the next generation of improved vaccine adjuvants. Journal of Controlled Release 190, pages 563-579.
Crossref
Crossref
Melissa C. Hanson, Anna Bershteyn, Monica P. Crespo & Darrell J. Irvine. (2014)
Antigen Delivery by Lipid-Enveloped PLGA Microparticle Vaccines Mediated by
in Situ
Vesicle Shedding
. Biomacromolecules 15:7, pages 2475-2481.
Crossref
Crossref
Woon Teck Yap, W. Kelsey Song, Niharika Chauhan, P. Nina Scalise, Radhika Agarwal, Stephen D. Miller & Lonnie D. Shea. (2014) Quantification of particle-conjugated or particle-encapsulated peptides on interfering reagent backgrounds. BioTechniques 57:1, pages 39-44.
Crossref
Crossref
Xiaoming Chen, Yuying Liu, Lianyan Wang, Yuan Liu, Weifeng Zhang, Bei Fan, Xiaowei Ma, Qipeng Yuan, Guanghui Ma & Zhiguo Su. (2014) Enhanced Humoral and Cell-Mediated Immune Responses Generated by Cationic Polymer-Coated PLA Microspheres with Adsorbed HBsAg. Molecular Pharmaceutics 11:6, pages 1772-1784.
Crossref
Crossref
Shu-Chun Chuang, Wan-Ling Huang, Sau-Wei Kau, Yun-Pei Yang & Chung-Da Yang. (2014) Pleurocidin Peptide Enhances Grouper Anti-Vibrio harveyi Immunity Elicited by Poly(lactide-co-glycolide)-Encapsulated Recombinant Glyceraldehyde-3-phosphate Dehydrogenase. Vaccines 2:2, pages 380-396.
Crossref
Crossref
Li-Ting Cheng, Yao-Chi Chung, Chung-Da Yang, Kuo-Pin Chuang, Guan-Ming Ke & Chun-Yen Chu. 2013. Toxinology. Toxinology
1
17
.
Anthony J. Hickey, Herman Staats, Chad J. Roy, Kenneth G. Powell, Vince Sullivan, Ginger Rothrock & Christie M. Sayes. 2014. Molecular Vaccines. Molecular Vaccines
717
726
.
Juan M. Irache, Ana I. Camacho & Carlos Gamazo. 2014. Mucosal Delivery of Biopharmaceuticals. Mucosal Delivery of Biopharmaceuticals
379
406
.
Shu-Chun Chuang, Jing-Chun Ko, Chaio-Ping Chen, Jia-Tze Du & Chung-Da Yang. (2013) Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles. Parasites & Vectors 6:1.
Crossref
Crossref
Annina M. Hafner, Blaise Corthésy & Hans P. Merkle. (2013) Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant. Advanced Drug Delivery Reviews 65:10, pages 1386-1399.
Crossref
Crossref
Shu-Chun Chuang, Jing-Chun Ko, Chaio-Ping Chen, Jia-Tze Du & Chung-Da Yang. (2013) Encapsulation of chimeric protein rSAG1/2 into poly(lactide-co-glycolide) microparticles induces long-term protective immunity against Toxoplasma gondii in mice. Experimental Parasitology 134:4, pages 430-437.
Crossref
Crossref
Gilles Bioley, Dietmar Zehn, Anne Lassus, Jacques Terrettaz, François Tranquart & Blaise Corthésy. (2013) The effect of vaccines based on ovalbumin coupled to gas-filled microbubbles for reducing infection by ovalbumin-expressing Listeria monocytogenes. Biomaterials 34:21, pages 5423-5430.
Crossref
Crossref
Luis A. Brito, Padma Malyala & Derek T. O’Hagan. (2013) Vaccine adjuvant formulations: A pharmaceutical perspective. Seminars in Immunology 25:2, pages 130-145.
Crossref
Crossref
A.L. Silva, R.A. Rosalia, A. Sazak, M.G. Carstens, F. Ossendorp, J. Oostendorp & W. Jiskoot. (2013) Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: Low-burst release is crucial for efficient CD8+ T cell activation. European Journal of Pharmaceutics and Biopharmaceutics 83:3, pages 338-345.
Crossref
Crossref
L. León-Rodríguez, A. Luzardo-Álvarez, J. Blanco-Méndez, J. Lamas & J. Leiro. (2013) Biodegradable microparticles covalently linked to surface antigens of the scuticociliate parasite P. dicentrarchi promote innate immune responses in vitro. Fish & Shellfish Immunology 34:1, pages 236-243.
Crossref
Crossref
Dharmendra Raghuwanshi, Vivek Mishra, Mavanur R. Suresh & Kamaljit Kaur. (2012) A simple approach for enhanced immune response using engineered dendritic cell targeted nanoparticles. Vaccine 30:50, pages 7292-7299.
Crossref
Crossref
Yang Sun, Yuanyi Zheng, Haitao Ran, Yang Zhou, Hongxia Shen, Yu Chen, Hangrong Chen, Tianyi M. Krupka, Ao Li, Pan Li, Zhibiao Wang & Zhigang Wang. (2012) Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation. Biomaterials 33:24, pages 5854-5864.
Crossref
Crossref
Joseph G. Altin. 2012. Innovation in Vaccinology. Innovation in Vaccinology
135
178
.